SCOTT KATHLEEN D. (Chief Financial Officer) sold 55.5% of their position (12.50K shares) of ARS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $187.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/22/2025ACC: 0001415889-25-022760
Officer· Chief Financial Officer
Since Nov 2022
-12.50K
Net shares
Net seller
$187.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.50K acquired · 25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.50K
Price / share
$1.50
Trade value
$18.75K
% of position
124.5%
8/21/2025
10.04K→22.54K
Common Stock
Direct
Shares
−12.50K
Price / share
$15.00
Trade value
$187.50K
% of position
55.5%
8/21/2025
22.54K→10.04K
Total
Net shares
+0.00
Net value
-$168.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2025 | M · Option Exercise | +12.50K | $1.50 | $18.75K | 124.5% | 10.04K | 22.54K |
| Common Stock Direct | 8/21/2025 | S · Sale | −12.50K | $15.00 | $187.50K | 55.5% | 22.54K | 10.04K |
| Total | +0.00 | -$168.75K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12.50K shares
Shares
−12.50K
Strike price
1.50
Held after
739.83K
Exercisable
—
8/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12.50K shares | 8/21/2025 | M · Option Exercise | −12.50K | 1.50 | — | 739.83K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned8.25K
Total
8.25K indirect8.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.25K | Indirect |
| Total | 8.25K | 8.25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported